Key facts
- Notable investors include Harvey & Company, Iron Path Capital, LongWater Opportunities.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for VION Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for VION Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VION Biosciences
Operator of a life science platform company intended for expanding domestic and global presence by acquiring specialty chemicals industries. The company delivers market-leading manufacturing and specialty reagents alongside value-added services to help in scientific discovery, clinical testing, therapeutic development and other services across a comprehensive platform, enabling clients to get the tools and expertise to fuel breakthrough discoveries.
- Sector
- Financial Services
- HQ
- Cleveland, OH, United States
- Founded
- 2023
- Website
- vionbiosciences.com/
- Ownership
- Privately Held (backing)
VION Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VION Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VION Biosciences in its N-PORT filings yet. We sweep new filings monthly.